Workflow
Astria Therapeutics (ATXS) 2025 Conference Transcript

Astria Therapeutics (ATXS) 2025 Conference May 07, 2025 10:30 AM ET Speaker0 Morning, everybody, and welcome to day one of the Citizens Life Science Conference. My name is John Wallabin, senior analyst here. We're pleased to have Astria Therapeutics and CEO, Jill Millney, joining us today. Astria is a company we launched coverage on, I think, earlier this year in January. We've been covering the hereditary angioedema space for quite some time, and I think this is one of the more compelling pipeline candidat ...